CopyMark Law Group
4.9/5
Drawing for MD ANDERSON

USPTO serial 98480259

MD ANDERSON

Reviewed by CopyMark Law Group

Reg. 7896459Status 700Registered
Filing date
Status date
Registration date
Aug 19, 2025
Examiner
LAWRENCE, SUSAN KASTRINER
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MD ANDERSON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robin Lightner Maisashvili

Robin Lightner Maisashvili Fibbe Lightner LLP3733-1 Westheimer Road, No. 1009Houston, TX 77027United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting on the establishment, management, and operation of cancer treatment centers; promoting collaboration within the scientific and medical communities to achieve advances in healthcare; promoting public awareness of cancer, cancer research, cancer prevention and cancer treatmentACTIVEJan 1, 1942
044Medical services; medical services, namely, cellular immunotherapy treatments; medical services, namely, human cancer treatment; providing medical information relating to immunotherapy; providing medical advice and consultancy regarding cancer therapies; medical and pharmaceutical consultation; medical services relating to cancer; dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer; medical consulting services, namely, consulting on the treatment of cancer; providing health information in the field of oncology, immunobiology, immunotherapy, and diseases; providing a web site featuring medical and health information; providing medical information, consultancy and advisory services; providing medical information relating to pharmaceuticals; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical analysis services, namely, analysis of tumors, cancer and related medical conditionsACTIVEJan 1, 1942
045Providing patient advocate services in the treatment of diseases and disorders; providing a website featuring supportive personal stories on the subjects of health and cancer; providing personal support services for patients and families of patients with cancer, namely, emotional counseling and emotional supportACTIVEJan 1, 1942

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 19, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 3, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 3, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 28, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 6, 2025PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 9, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 9, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Apr 9, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 9, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 9, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 17, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 17, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 17, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 17, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 15, 2024DOCKASSIGNED TO EXAMINER—
Sep 7, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 2, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance